| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HBIO | Common Stock | Award | $0 | +157K | +7.94% | $0.00 | 2.13M | Mar 1, 2022 | Direct | F1, F2 |
| transaction | HBIO | Common Stock | Award | $0 | +145K | +6.81% | $0.00 | 2.28M | Mar 1, 2022 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | Represents an award of 157,037 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, subject to the terms set forth in an award agreement between the Issuer and the Reporting Person. |
| F2 | Includes (a) the award described in footnote (1) above, (b) 218,140 remaining restricted stock units that will vest on June 11, 2022 and 2023, (c) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (d) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (e) 104,590 remaining restricted stock units that will vest on January 1, 2023, (f) 395,853 restricted stock units with performance based vesting conditions tied to relative total shareholder return, and (g) 1,020,101 shares of common stock beneficially owned by the Reporting Person. |
| F3 | Represents an award of 145,365 restricted stock units with performance based vesting conditions. These restricted stock units will vest upon the achievement of a relative total shareholder return of the Issuer's common stock during the period from March 1, 2022 to the earlier of (i) December 31, 2024, and (ii) the date of a change of control (the "Measurement Period"), measured relative to the Russell 2000 index and based on the 20-day trading average beginning on the first day of the Measurement Period and ending on the last day of the Measurement Period, subject to the terms set forth in an award agreement between the Issuer and the Reporting Person. The target number of these restricted stock units that may be earned is reported above; the maximum amount is 150% of the number reported. |
| F4 | Includes (a) the shares and awards described in footnote (2) above, and (b) the award described in footnote (3) above. |